Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-04

Clinical Trial Update: Intravitreal Injections of Ziv-aflibercept for Macular Diseases [NA]

View source ↗

Summary

This clinical trial update notes completion of an intravitreal ziv-aflibercept study for macular diseases, including diabetic macular edema, age-related macular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Retina Clinic, Sao Paulo, Brazil | Conditions: Diabetic Macular Edema, Age Related Macular Degeneration | NA | Status: COMPLETED